UNITED STATES
                        SECURITIES AND EXCHANGE COMMISSION
                              Washington, D.C. 20549

                                    FORM 10-Q/A


                        AMENDMENT TO APPLICATION OR REPORT

                        Filed pursuant to Section 12, 13, or 15(d) of THE
                        SECURITIES EXCHANGE ACT OF 1934
                    
                        DEKALB Genetics Corporation
                        ---------------------------
                        (Exact name of registrant as specified in charter)

                        AMENDMENT NO. 1

        The undersigned registrant hereby amends the following items, financial 
statements, exhibits or other portions of its Quarterly Report for the three 
month period ended November 30, 1995 on form 10-Q as set forth in the pages 
attached hereto: 

Exhibit 27 - Financial Data Schedule

Exhibit 27 - Restated Financial Data Schedule for the three month period
             ended November 30, 1994

        Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this amendment to be signed on its behalf by
the undersigned, thereunto duly authorized.

Date:  February 21, 1996



Item 6.  Exhibits and Reports on Form 8-K                 Page
- -----------------------------------------                 ----


(a) Exhibit 11 - Earnings Per Share Computation              12

    Exhibit 27 - Financial Data Schedule

    Exhibit 27 - Restated Financial Data Schedule

    For the three month period ended November 30, 1994

(b) Reports on Form 8-K -

    No Form 8-K was filed during the three months ended November 30, 1995.



                            SIGNATURE
                            ---------

Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.

                          DEKALB Genetics Corporation
                          ---------------------------




Date: February 21, 1996          Thomas R. Rauman
                       ---------------------------------

                                  (Signature)
                                Thomas R. Rauman
                            Vice President-Finance,
                            Chief Financial Officer